...
首页> 外文期刊>The Southeast Asian journal of tropical medicine and public health >Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis.
【24h】

Double-dose ivermectin vs albendazole for the treatment of gnathostomiasis.

机译:伊维菌素与阿苯达唑双剂量用于治疗口臭。

获取原文
获取原文并翻译 | 示例

摘要

A comparative study was performed for the treatment of gnathostomiasis patients with ivermectin 0.2 mg/kg for 2 days in 15 patients vs albendazole 400 mg twice daily for 21 days in 14 patients. The ivermectin and albendazole gave cure rates of 100% and 78.5%, respectively, however the difference was not statistically significant between the two drugs (Fisher's exact, p=0.0996). One year after treatment, the patients who had no migratory swellings and a drop in ELISA titers or a negative immunoblot test were considered to be cured. The side effect of ivermectin for two days was dizziness. The side effects of albendazole were nausea, dizziness, and an increased alkaline phosphatase.
机译:进行了一项对比研究,对15例患者使用伊维菌素0.2 mg / kg联合2天内每天两次阿苯达唑400 mg治疗21天内的遗弃症患者进行了21天的治疗。伊维菌素和阿苯达唑的治愈率分别为100%和78.5%,但是两种药物之间的差异在统计学上无统计学意义(Fisher精确,p = 0.0996)。治疗一年后,没有迁徙性肿胀,ELISA滴度下降或免疫印迹试验阴性的患者被治愈。伊维菌素持续两天的副作用是头晕。阿苯达唑的副作用是恶心,头晕和碱性磷酸酶升高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号